InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,572.85
(
0.10%
)
US TECH 100
19,963.60
(
0.59%
)
Dow Jones
39,344.79
(
-0.08%
)
Brent Oil
85.57
(
0.18%
)
Bitcoin
57,438.48
(
1.29%
)

Replies to post #52100 on $heff's $tation of $tocks & $olid DD

Replies to #52100 on $heff's $tation of $tocks & $olid DD

$heff

03/01/12 3:16 AM

#52162 RE: $heff #52100

ONXX..$38.32 Target enrollment reached for the ASPIRE trial, evaluating carfilzomib + lenalidomide/ dexamethasone in pts with relapsed multiple myeloma. (Medscape Oncology)